Lipid mediators derived from DHA alleviate DNCB-induced atopic dermatitis and improve the gut microbiome in BALB/c mice
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110900 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Yan Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup-Si 56212, South Korea; Department…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Gastrointestinal Microbiome, Docosahexaenoic Acids, Anti-Inflammatory Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Research Institute of Bioscience and Biotechnology, National Research Foundation of Korea, Korea Ministry of Science and ICT.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic inflammatory skin condition that primarily results from immune dysregulation. We determined the potential therapeutic benefits of lipid mediators (LM, 17S-monohydroxy DHA, resolvin D5, and protectin DX in a ratio of 3:47:50) produced by soybean lipoxygenase from DHA. The underlying molecular mechanisms involved in TNF-α/IFN-γ-stimulated HaCaT cells as well as its effect in an AD mouse model induced by DNCB in BALB/c mice were examined. The results indicated that LM effectively attenuates the production of inflammatory cytokines (IL-6 and IL-1β) and chemokines (IL-8 and MCP-1) by inhibiting the NF-κB signaling pathway in TNF-α/IFN-γ-stimulated HaCaT cells. The oral administration of LM at 5 or 10 μg/kg/day significantly reduced skin lesions, epidermal thickness, and mast cell infiltration in AD mice. Furthermore, LM reduced the production of IgE and inflammatory cytokines (TNF-α, IL-6, and IL-1β) in the serum, modulated gut microbiota diversity, and restored the microbial composition. Overall, our findings suggest that LM represents a potential therapeutic agent for improving AD symptoms through its ability to suppress inflammatory cytokines and alter the composition of gut microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup-Si 56212, South Korea; Department of Bioactive Material Sciences, Jeonbuk National University, Jeonju 5…
- Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup-Si 56212, South Korea. Electronic address: gugin@kribb.re.kr.
- Faculty of Biotechnology, College of Applied Life Sciences, Jeju National University, Jeju 63243, South Korea. Electronic address: choix074@jejunu.ac.kr.
- Healthcare Technology Institute, Kolon Advanced Research Center, 110 Magokdong-ro, Seoul 07793, South Korea. Electronic address: enlicoo@kolon.com.
- Healthcare Technology Institute, Kolon Advanced Research Center, 110 Magokdong-ro, Seoul 07793, South Korea. Electronic address: heewoncho@kolon.com.
- Healthcare Technology Institute, Kolon Advanced Research Center, 110 Magokdong-ro, Seoul 07793, South Korea. Electronic address: heonsik@kolon.com.
Förderung
- Korea Research Institute of Bioscience and Biotechnology
- National Research Foundation of Korea
- Korea Ministry of Science and ICT
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Su, Y., Han, Y., Choi, H. S., Lee, G. Y., Cho, H. W., Choi, H., Jang, Y. S., Choi, J. H., & Seo, J. W. (2023). Lipid mediators derived from DHA alleviate DNCB-induced atopic dermatitis and improve the gut microbiome in BALB/c mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110900
Vancouver
Su Y, Han Y, Choi HS, Lee GY, Cho HW, Choi H, et al. Lipid mediators derived from DHA alleviate DNCB-induced atopic dermatitis and improve the gut microbiome in BALB/c mice. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110900
BibTeX
@article{Su2023,
author = {Su, Yan and Han, Yunjon and Choi, Hack Sun and Lee, Gil-Yong and Cho, Hee Won and Choi, Heonsik and Jang, Yong-Suk and Choi, Jong Hyun and Seo, Jeong-Woo},
title = {Lipid mediators derived from DHA alleviate DNCB-induced atopic dermatitis and improve the gut microbiome in BALB/c mice},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110900}
}
EUVIMED